scholarly journals New human renin inhibitory peptides. Angiotensinogen transition-state analogues containing novel Leu-Val replacement and a retro-inverso amide bond.

1988 ◽  
Vol 36 (6) ◽  
pp. 2278-2281 ◽  
Author(s):  
Kinji Iizuka ◽  
Tetsuhide Kamijo ◽  
Hiromu Harada ◽  
Kenji Akahane ◽  
Tetsuhiro Kubota ◽  
...  
1990 ◽  
Vol 38 (11) ◽  
pp. 3042-3047 ◽  
Author(s):  
Hiromu HARADA ◽  
Kinji IIZUKA ◽  
Tetsuhide KAMIJO ◽  
Kenji AKAHANE ◽  
Ryoji YAMAMOTO ◽  
...  

ChemBioChem ◽  
2011 ◽  
Vol 12 (13) ◽  
pp. 1996-2000 ◽  
Author(s):  
Verena Gehmayr ◽  
Christa Mollay ◽  
Lorenz Reith ◽  
Norbert Müller ◽  
Alexander Jilek

2020 ◽  
Author(s):  
coralie assailly ◽  
clarisse bridot ◽  
amélie saumonneau ◽  
paul lottin ◽  
Benoit Roubinet ◽  
...  

<div>Conjugation of the transitionstate-cation analogue DANA to polymeric scaffolds led to highly potent inhibitors of bacterial sialidases. Each clustered DANA on the polymers saw its inhibitory potency for S. pneumoniae or B. thetaiotaomicron sialidases improved by more than four orders of magnitude. This extends the multivalent concept to this important class of enzymes.</div><div><br></div>


2020 ◽  
Vol 142 (33) ◽  
pp. 14222-14233 ◽  
Author(s):  
Niusha Mahmoodi ◽  
Rajesh K. Harijan ◽  
Vern L. Schramm

2017 ◽  
Vol 23 (72) ◽  
pp. 18289-18295 ◽  
Author(s):  
Khushboo M. Patel ◽  
David Teran ◽  
Shan Zheng ◽  
Ajit Kandale ◽  
Mario Garcia ◽  
...  

Biomolecules ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. 854 ◽  
Author(s):  
Antonela R. Palacios ◽  
María-Agustina Rossi ◽  
Graciela S. Mahler ◽  
Alejandro J. Vila

β-Lactam antibiotics are the most widely prescribed antibacterial drugs due to their low toxicity and broad spectrum. Their action is counteracted by different resistance mechanisms developed by bacteria. Among them, the most common strategy is the expression of β-lactamases, enzymes that hydrolyze the amide bond present in all β-lactam compounds. There are several inhibitors against serine-β-lactamases (SBLs). Metallo-β-lactamases (MBLs) are Zn(II)-dependent enzymes able to hydrolyze most β-lactam antibiotics, and no clinically useful inhibitors against them have yet been approved. Despite their large structural diversity, MBLs have a common catalytic mechanism with similar reaction species. Here, we describe a number of MBL inhibitors that mimic different species formed during the hydrolysis process: substrate, transition state, intermediate, or product. Recent advances in the development of boron-based and thiol-based inhibitors are discussed in the light of the mechanism of MBLs. We also discuss the use of chelators as a possible strategy, since Zn(II) ions are essential for substrate binding and catalysis.


1990 ◽  
Vol 38 (9) ◽  
pp. 2487-2493 ◽  
Author(s):  
Kinji IIZUKA ◽  
Tetsuhide KAMIJO ◽  
Hiromu HARADA ◽  
Kenji AKAHANE ◽  
Tetsuhiro KUBOTA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document